Gilead

The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its artificial-intelligence drug design pipeline across multiple therapeutic areas.

Data from AbbVie and Johnson & Johnson will fine-tune OpenFold3 in a confidentiality-preserving environment, powered by Apheris.

GEP®, a leading provider of AI-driven procurement and supply chain software and services for Fortune 500 and Global 2000 enterprises worldwide, announced that GEP SOFTWARE™ has once again secured the top ranking in source-to-pay (S2P),

Seeking more efficient drug development, pharmaceutical giants and startups are encouraging AI fluency and in some cases offering training for it.

ROSELAND, NJ, March 04, 2025 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (Nasdaq: GXAI) ("the Company"), a company developing artificial intelligence applications across various sectors, today announced that the Company has reincorporated in the State of Nevada from State of Delaware (the "Reincorporation").

Beyond speed, AI has also helped reduce costs. Conventional methods required nearly $35,000 per genome analysis, but AI-driven models running on GPUs have lowered the cost to under $2,000, making high-quality genomic research more accessible.

Telescope Innovations Corp. (CSE:TELI) is leveraging its expertise to advance chemistry process development and crystallization optimization in pharmaceuticals, industrial chemicals, and critical minerals ・Telescope's Self-Driving Labs (SDLs) integrate AI,

This new approach, powered by a specialised protein large language model, predicts the most effective protein variants while using 99% less data than traditional methods.